BPC-157 + TB-500 + KPV 30mg Pen Bali
Rp3,800,000.00 ~$230.30
Discover the Atlas Longevity BPC-157 + TB-500 + KPV 30mg Peptide Pen, an experimental three-peptide formulation featuring BPC-157, TB-500 and KPV in a convenient pre-mixed 3mL cartridge.
Each pen contains:
- BPC-157: 10mg
- TB-500: 10mg
- KPV: 10mg
- Total: 30mg
- Cartridge: 3mL
- Pen Capacity: 300 volumetric units
- Format: Pre-mixed peptide pen
The individual compounds are investigated in tissue biology, cellular signalling and inflammation-related research.
For laboratory research only. Not approved for human administration.
Available on backorder
- COA Verified
- Same-Day Dispatch
- Ships from Bali
- SSL Secure
BPC-157 + TB-500 + KPV 30mg Peptide Pen Bali
Triple Peptide Research Blend
The Atlas Longevity 30mg Triple Peptide Pen combines three experimental peptides with distinct research profiles.
BPC-157 has been investigated in preclinical injury-response models, TB-500 is associated with thymosin beta-4-related research, and KPV has been studied in inflammation-associated signalling.
The safety and effectiveness of this specific combined formulation have not been established through adequate human clinical trials.
What’s Inside?
| Ingredient | Amount | Research Focus |
|---|---|---|
| BPC-157 | 10mg | Tissue and injury-response biology |
| TB-500 | 10mg | Cellular movement and tissue signalling |
| KPV | 10mg | Inflammatory and immune signalling |
| Total | 30mg | Experimental research formulation |
What Is BPC-157?
BPC-157 is a synthetic peptide consisting of 15 amino acids.
Preclinical research has investigated its involvement in:
- Tendon and ligament biology
- Tissue responses to injury
- Gastrointestinal tissue models
- Inflammatory signalling
- Cellular repair mechanisms
Human clinical evidence remains insufficient to establish therapeutic benefits.
What Is TB-500?
TB-500 is a product name associated with thymosin beta-4-related peptide research.
Thymosin beta-4 is involved in actin regulation and cell movement. Related research has explored cellular migration, wound-response biology and tissue organisation.
The precise peptide sequence labelled TB-500 can vary between suppliers, making ingredient identification important.
What Is KPV?
KPV is a tripeptide consisting of lysine, proline and valine.
Experimental studies have investigated its relationship with:
- Inflammatory pathways
- Immune-cell signalling
- Intestinal inflammation models
- Skin and tissue biology
These findings do not establish KPV as an approved treatment for inflammatory disorders.
Research Areas
The individual ingredients have been investigated in relation to:
- Tissue biology
- Cellular signalling
- Connective tissue research
- Inflammation-associated mechanisms
- Cell migration
- Gastrointestinal tissue models
- Immune-response pathways
Combining these peptides does not automatically establish improved efficacy or safety.
Atlas Longevity Pen Specifications
| Specification | Details |
|---|---|
| Brand | Atlas Longevity |
| Product | BPC-157 + TB-500 + KPV Blend |
| Total Labelled Content | 30mg |
| BPC-157 | 10mg |
| TB-500 | 10mg |
| KPV | 10mg |
| Cartridge Volume | 3mL |
| Total Volumetric Units | 300 |
| Volume Per Unit | 0.01mL |
| Dial Range | 1–60 units |
| Format | Pre-mixed research peptide pen |
The pen dial resets to zero after operation. Remaining cartridge contents stay in the pen.
Pre-Mixed Formulation
This product is presented in a pre-mixed cartridge format.
The combined formulation requires appropriate testing for chemical stability, peptide compatibility, ingredient identity and microbiological quality.
A pre-filled pen presentation does not establish suitability for human injection.
Quality Documentation
Contact Atlas Longevity to request available batch-specific analytical documentation.
For multi-peptide formulations, suitable testing should distinguish and quantify the individual compounds.
A purity Certificate of Analysis does not establish sterility or clinical safety.
Storage
Follow the verified storage instructions for the specific formulation and batch.
Protect from excessive heat, sunlight and contamination.
The shelf life of a pre-mixed three-peptide cartridge requires formulation-specific stability evidence.
Safety Information
The combined formulation has not been adequately evaluated for human safety or effectiveness.
Potential adverse effects, interactions and long-term risks remain inadequately characterised.
There is no medically established dosing protocol for this specific blend.
Atlas Longevity Bali
Atlas Longevity provides information about experimental peptide formulations, research specifications and available analytical documentation.
Contact our team for product information and regulatory enquiries.
Any supply must comply with applicable Indonesian regulations.
Frequently Asked Questions
What is BPC-157 + TB-500 + KPV Blend?
It is an experimental formulation combining BPC-157, TB-500 and KPV.
How much peptide does the pen contain?
The pen is labelled as containing 30mg total: 10mg BPC-157, 10mg TB-500 and 10mg KPV.
What is BPC-157 researched for?
BPC-157 has been investigated in preclinical tissue, injury-response and inflammation-related research.
What is TB-500 researched for?
TB-500 is associated with thymosin beta-4-related research involving cell movement and tissue biology.
What is KPV researched for?
KPV has been investigated in experimental inflammatory and immune-signalling pathways.
Is this the same as Wolverine Blend?
Not necessarily. Wolverine Blend commonly refers to BPC-157 and TB-500 combinations, while this formulation also contains KPV.
Is this blend proven to accelerate injury recovery?
No. Adequate human clinical evidence has not established that this specific combination accelerates injury recovery.
How many units are in the pen?
The 3mL Atlas Pen contains 300 volumetric units, each representing 0.01mL.
Does the pen require mixing?
No separate mixing step is part of the supplied pre-mixed research formulation.
Is this pen approved for medical use?
No. This combined formulation is not an established approved medical treatment.
Is this pen suitable for injection?
A pre-filled pen format and peptide purity testing do not establish sterility or suitability for human injection.
Is a Certificate of Analysis available?
Contact Atlas Longevity to request available batch-specific analytical documentation.
How should the pen be stored?
Follow the verified batch-specific storage instructions and expiry information.
Research Disclaimer
For laboratory research only. Not for human consumption or self-administration.
The safety, effectiveness and stability of this combined peptide formulation have not been established for human administration.
This product is not intended to diagnose, treat, cure or prevent any disease.
- Angiogenesis research — published research has investigated effects on VEGF expression and new blood vessel formation
- Tissue repair studies — extensively studied in preclinical models of tendon, ligament, and muscle repair
- Gastrointestinal research — investigated in animal models of GI epithelial integrity
- Anti-inflammatory pathways — studied in preclinical research on inflammatory signalling
- Customer reports — users in our community commonly describe improvements in joint and soft-tissue comfort within 2–4 weeks of research protocols; individual results vary
- Research use only — for in-vitro and laboratory research applications

Peptide Vials
Peptide Nasal Sprays
Peptide Protocols
Bundles